Search
Close this search box.

CBD for Cancer: Existing Research & Potential Benefits 

Despite advancements in cancer research and conventional cancer treatments (such as chemo, radiation and surgery), there is a demand for alternative therapies that can improve treatment outcomes and enhance the quality of life for cancer patients. This includes Cannabidiol (CBD), which could help manage symptoms of the disease and side effects of treatment. In this article, we’ll look at what CBD is, what existing scientific research says on the relationship between the two, and how CBD may help the treatment and management of cancer.

Cannabinoids are naturally occurring compounds found in the Cannabis sativa plant. Of over 480 different compounds present in the plant, only around 66 are termed cannabinoids. 

According to Cancer Research UK, research has shown that different cannabinoids can cause cell death, block cell growth, stop the development of blood vessels (which is needed for tumours to grow), reduce inflammation, and reduce the ability of cancers to spread, which could make them useful as a cancer treatment. They continue that some cannabinoids have also helped with sickness and pain, which could benefit the symptoms and side effects of cancer and related treatments. Indeed, in the UK, there are two cannabis-derived products that can be prescribed if you have sickness or vomiting caused by chemotherapy (when other anti-sickness medicines haven’t helped): Nabilone and Sativex

The most well known among these cannabis compounds is delta-9-tetrahydrocannabinol (THC), but cannabidiol (CBD) is another important one.

Cannabidiol, better known as CBD, is one of the compounds found in the cannabis plant. Unlike THC, CBD is a non-psychoactive compound and does not induce the “high” or other intoxication symptoms often associated with cannabis. Instead, CBD interacts with our endocannabinoid system (ECS) and influences its CB1 and CB2 receptors, which can help to regulate several of our cognitive and physical functions, such as pain, mood, appetite and stress. This makes it a promising solution for several conditions and symptoms, such as migraines, seizures, osteoporosis, and depression

There is also growing interest in how it could modulate various factors involved in cancer progression and treatment response. Indeed, as reported in Cannabidiol (CBD) in Cancer Management, CBD has a range of therapeutic actions that demonstrate the potential relevance of CBD to cancer. 

  • analgesic
  • anti-nausea
  • anti-emetic
  • anxiolytic
  • antidepressant
  • anti-psychotic
  • anti-convulsant/anti-epileptic
  • anti-asthmatic immune-modulatory
  • antioxidant
  • anti-inflammatory
  • antibiotic, anti-bacterial
  • neuroprotective
  • anti-cancer and anti-tumoral

In addition to this, a report on CBD from the Expert Committee on Drug Dependence at the World Health Organization (WHO) found that CBD does not induce major side effects or physical dependence, does not get you high, and is not associated with abuse potential. In fact, to date, there is no evidence of public health related problems associated with the use of CBD, and their report found that naturally occurring CBD is safe and well tolerated in humans. CBD is also legal to purchase in the UK as long as it contains less than 0.2% THC. 

Various preclinical studies have demonstrated that CBD could have anti-cancer effects in relation to both the treatment and management of cancer and related symptoms.

  • In a mice model of melanoma, CBD treatment was associated with a significant reduction in tumour size compared with placebo, and increased survival rate.

  • Preclinical data ‘strongly supports’ the notion that non-psychoactive plant-derived CBs can act as direct inhibitors of tumour progression, as well as enhance the activity of first-line therapies.

  • Glioma cell research demonstrates CBD alone or in conjunction with other agents can induce cell death, inhibit cell migration and invasion, reduce size of tumours, reduce vascularisation, and induce tumour regression and increase survival. 

  • Leukaemia cell research found that CBD reduced their ability to survive and caused them to undergo apoptosis (cell death). When they tested this in living organisms, they saw that CBD treatment decreased the overall tumour size and increased the number of tumours undergoing apoptosis.

  • 2014 study in experimental models of colon cancer in vivo suggests that CBD may inhibit the spread of colorectal cancer cells.

  • In a 2023 study using mice with modified human glioblastoma cells, inhaled CBD limited tumour growth and enhanced the immune response against cancer cells.

More research is needed to investigate and understand the full effects of CBD on cancer. 

There are many related signs and symptoms endured by people living with cancer, due to the cancer itself and/or its treatment. This includes stress, anxiety and depression, nausea and vomiting, pain, neuropathy, fatigue and poor sleep. In conjunction with conventional treatment, CBD may be useful for both treating and managing cancer and related symptoms.

Oxidative stress can contribute to cancer initiation and progression. As CBD has anti-inflammatory and antioxidant properties, it could help to reduce the physical effects of stress, and play a part in preventing stress-related conditions. Thus, CBD’s antioxidant properties could reduce oxidative damage, and potentially mitigate cancer-associated oxidative stress.

Chronic inflammation plays a pivotal role in cancer development and progression by promoting tumour growth, angiogenesis, and metastasis. CBD’s anti-inflammatory properties have been well-documented in preclinical studies, suggesting its potential role in inflammation-driven carcinogenesis (cancer formation).

Apoptosis, or cell death, is crucial for eliminating damaged cells, including cancer cells. One study found that CBD can induce apoptosis by activating caspases (enzymes that play a key role in apoptosis) and triggering the release of certain molecules and other caspase enzymes involved in the cell death process. When researchers exposed normal brain cells to CBD under the same conditions, they didn’t see the same effects, which suggests that CBD is selectively targeting the cancer cells while leaving the healthy cells alone.

This is supported by a later 2017 study in which CBD, alongside radiation, made glioblastoma cells more sensitive to radiation and increase their chances of dying (cell death).

Schematic diagram of different mechanisms/signalling pathways of cannabinoids affecting autophagy and apoptosi.

 Schematic diagram of different mechanisms/signalling pathways of cannabinoids affecting autophagy and apoptosis, via Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: A review.

CBD has been reported to inhibit angiogenesis by multiple mechanisms. Its dual effect on both tumour and endothelial cells supports the hypothesis that CBD has potential as an effective agent in cancer therapy. Indeed, one study found that CBD inhibited angiogenesis related to the proliferation of estrogen receptor-positive breast cancer.

Chemotherapy-induced nausea and vomiting occurs in approximately 29% of patients. While traditional medication can treat vomiting, anti-nausea medicine isn’t as effective. CBD, on the other hand, has been linked to nausea and vomiting relief in various animal studies. One 2016 study found that CBD is a highly effective antinausea treatment without producing sedation or psychoactive effects, which means it could improve the quality of life of patients undergoing cancer treatment by reducing the side effects of nausea and anticipatory nausea when it develops.

Cancer-related pain is another common symptom in cancer patients. CBD has proven analgesic (pain-relieving) properties, which could help patients to manage pain without relying on opiods. For example, in an open-label follow-up study of 43 patients experiencing inadequate analgesia despite chronic opioid use, patients using a combination of THC and CBD showed improvements in pain, fatigue and insomnia. Patients taking THC/CBD also needed significantly fewer doses of breakthrough pain medication in comparison with placebo. 

Anxiety and depression often co-exist in cancer patients. Preclinical and clinical evidence indicates that CBD has anxiolytic (anti-anxiety) effects which could help to reduce stress, depression and anxiety-like behaviours. Indeed, of 387 current or past-CBD users, 42.6% use CBD for anxiety and 37% use CBD for stress. Of those 42.6%, 86.5% responded that they felt less anxious. And for those using CBD for stress, 92.2% responded that they felt less stressed. 

Lack of sleep is common in newly diagnosed, recently treated and post-treatment cancer patients. CBD has been linked to longer and “better” sleep, due to its relaxing and sometimes sedating effects. 

In a 2022 study on cannabidiol as a treatment for arthritis and joint pain, CBD use was associated with improvements in pain (83%), physical function (66%), and sleep quality (66%).

In conclusion, CBD holds significant promise as a therapeutic agent for cancer, offering a multifaceted approach to symptom management, tumour suppression, and quality of life improvement. Preclinical studies support CBD’s anti-cancer effects through various mechanisms, but clinical trials are required to demonstrate its safety and tolerability in cancer patients.

If you’re considering using CBD to manage cancer symptoms, it is essential to talk to your doctor first about the potential benefits and risks of CBD, what to look for, and where to purchase it. If you’re currently being treated for cancer, keep in mind that many substances can interact with other therapies, including CBD.

  • Medications: CBD has the potential to interact with certain medications, so it’s important to consult with a healthcare professional before taking CBD.

  • Type of CBD: Broad-spectrum CBD is a great option for those who want to experience the effects of CBD without consuming THC, the psychoactive compound in the cannabis plant. Clinical reports suggest that broad or full-spectrum CBD may have a better effect due to the number of cannabinoids and other plant compounds they contain that work together, otherwise known as the entourage effect

  • Dosage: Finding the right dose and administration method can be a trial-and-error process as results can vary significantly from person to person. In general, you should start with a low dose and gradually increase it while monitoring its effects.

  • Source and Quality: Choose CBD derived from organically grown hemp, as this ensures minimal exposure to harmful chemicals. You should also look for third-party laboratory reports to verify how pure and potent your product is, and to ensure there are no contaminants.

  • Individual Variability: The effectiveness of CBD may vary from person to person; what works for one individual may not work for another.

  • A, Shrivastava, et al. “Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-Talk between Apoptosis and Autophagy.” Molecular Cancer Therapeutics, 1 July 2011, pubmed.ncbi.nlm.nih.gov/21566064/.

  • “BNF Is Only Available in the UK.” NICE, bnf.nice.org.uk/drugs/nabilone/.

  • “Cannabis, CBD Oil and Cancer| Cancer Research UK.” Www.cancerresearchuk.org, www.cancerresearchuk.org/about-cancer/treatment/complementary-alternative-therapies/individual-therapies/cannabis.

  • “Entourage Effect.” Wikipedia, 1 Feb. 2023, en.wikipedia.org/wiki/Entourage_effect.

  • Frane, Nicholas, et al. “Cannabidiol as a Treatment for Arthritis and Joint Pain: An Exploratory Cross-Sectional Study.” Journal of Cannabis Research, vol. 4, no. 1, 24 Aug. 2022, https://doi.org/10.1186/s42238-022-00154-9.

  • Fu, Ze, et al. “Cannabidiol Regulates Apoptosis and Autophagy in Inflammation and Cancer: A Review.” Frontiers in Pharmacology, vol. 14, 23 Jan. 2023, https://doi.org/10.3389/fphar.2023.1094020.

  • Ivanov, Vladimir N., et al. “Regulation of Human Glioblastoma Cell Death by Combined Treatment of Cannabidiol, γ-Radiation and Small Molecule Inhibitors of Cell Signaling Pathways.” Oncotarget, vol. 8, no. 43, 27 May 2017, https://doi.org/10.18632/oncotarget.18240.

  • Jo, Min Jee, et al. “Cannabidiol Suppresses Angiogenesis and Stemness of Breast Cancer Cells by Downregulation of Hypoxia-Inducible Factors-1α.” Cancers, vol. 13, no. 22, 12 Nov. 2021, p. 5667, https://doi.org/10.3390/cancers13225667.

  • Johnson, Jeremy R., et al. “An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients with Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics.” Journal of Pain and Symptom Management, vol. 46, no. 2, Aug. 2013, pp. 207–218, https://doi.org/10.1016/j.jpainsymman.2012.07.014.

  • Kisková, Terézia, et al. “Future Aspects for Cannabinoids in Breast Cancer Therapy.” International Journal of Molecular Sciences, vol. 20, no. 7, 3 Apr. 2019, www.ncbi.nlm.nih.gov/pmc/articles/PMC6479799/, https://doi.org/10.3390/ijms20071673.

  • Ligresti, Alessia, et al. “Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma.” Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 3, 25 May 2006, pp. 1375–1387, jpet.aspetjournals.org/content/318/3/1375, https://doi.org/10.1124/jpet.106.105247.

  • Massi, P., et al. “The Non-Psychoactive Cannabidiol Triggers Caspase Activation and Oxidative Stress in Human Glioma Cells.” Cellular and Molecular Life Sciences, vol. 63, no. 17, 10 Aug. 2006, pp. 2057–2066, https://doi.org/10.1007/s00018-006-6156-x.

  • McAllister, Sean D., et al. “The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.” Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, vol. 10, no. 2, 1 June 2015, pp. 255–267, www.ncbi.nlm.nih.gov/pubmed/25916739, https://doi.org/10.1007/s11481-015-9608-y.

  • McKallip, R. J. “Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of P22phox and Nox4 Expression.” Molecular Pharmacology, vol. 70, no. 3, 20 June 2006, pp. 897–908, https://doi.org/10.1124/mol.106.023937.

  • Moltke, Julie, and Chandni Hindocha. “Reasons for Cannabidiol Use: A Cross-Sectional Study of CBD Users, Focusing on Self-Perceived Stress, Anxiety, and Sleep Problems.” Journal of Cannabis Research, vol. 3, no. 1, 18 Feb. 2021, https://doi.org/10.1186/s42238-021-00061-5.

  • “Nausea and Vomiting and Cancer Treatment – Side Effects – National Cancer Institute.” Www.cancer.gov, 29 Apr. 2015, www.cancer.gov/about-cancer/treatment/side-effects/nausea-vomiting.

  • News-Medical. “What Are Cannabinoids?” News-Medical.net, 2 June 2010, www.news-medical.net/health/What-are-Cannabinoids.aspx.

  • O’Brien, Kylie. “Cannabidiol (CBD) in Cancer Management.” Cancers, vol. 14, no. 4, 10 Feb. 2022, p. 885, https://doi.org/10.3390/cancers14040885.

  • Rock, Erin M., et al. “Cannabinoid Regulation of Acute and Anticipatory Nausea.” Cannabis and Cannabinoid Research, vol. 1, no. 1, Dec. 2016, pp. 113–121, https://doi.org/10.1089/can.2016.0006.

  • Romano, Barbara, et al. “Inhibition of Colon Carcinogenesis by a Standardized Cannabis Sativa Extract with High Content of Cannabidiol.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, vol. 21, no. 5, 15 Apr. 2014, pp. 631–639, pubmed.ncbi.nlm.nih.gov/24373545/, https://doi.org/10.1016/j.phymed.2013.11.006.

  • “Sativex.” Www.mssociety.org.uk, 17 Aug. 2021, www.mssociety.org.uk/about-ms/treatments-and-therapies/cannabis/sativex.

  • Seltzer, Emily S., et al. “Cannabidiol (CBD) as a Promising Anti-Cancer Drug.” Cancers, vol. 12, no. 11, 30 Oct. 2020, p. 3203, https://doi.org/10.3390/cancers12113203.

  • Simmerman, Erika, et al. “Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model.” The Journal of Surgical Research, vol. 235, 2019, pp. 210–215, www.ncbi.nlm.nih.gov/pubmed/30691796, https://doi.org/10.1016/j.jss.2018.08.055.

  • Solinas, M, et al. “Cannabidiol Inhibits Angiogenesis by Multiple Mechanisms.” British Journal of Pharmacology, vol. 167, no. 6, 19 Oct. 2012, pp. 1218–1231, https://doi.org/10.1111/j.1476-5381.2012.02050.x.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Leave a comment

Please provide your details below to download the ultimate guide to CBD

Directions for Use:

  • Shake well before use
  • Add dose directly to your pet’s food, stirring it in if necessary
  • Use up to twice daily – (See dosage table for guidelines)
  • Store in a cool dry place out of direct sunlight

Weight of Pet Regular Dosage Strong Dosage
Up to 20lbs/9kg 1 to 4 drops 4 to 8 drops
20 to 40lbs/9-18kg 2 to 8 drops 8 to 16 drops
Over 40lbs/18kg 4 to 20 drops 16 to 40 drops

Contains Zero THC, chlorophyll free

*This product is sold for use by pets only, as it contains CBD Isolate.

We recommend discussing the use of CBD with a qualified vet, especially if your pet is pregnant or nursing a litter.

Keep out of sight or reach of children.